250 ORAL OXA-01, a novel potent mTORC1/TORC2 kinase...

European Journal of Cancer Supplements 2008 Vol. 6; Iss. 12

250 ORAL OXA-01, a novel potent mTORC1/TORC2 kinase inhibitor, demonstrates broad spectrum antitumor activity in preclinical models of human cancer

P.C. Gokhale, S.V. Bhagwat, A.P. Crew, A. Cooke, C. Mantis, J.E. Workman, D. Landfair, M. Bittner, J.A. Pachter, R. Wild
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72184-0
File:
PDF, 59 KB
english, 2008
Conversion to is in progress
Conversion to is failed